Type 2 diabetes mellitus is a common chronic disease that develops in most populations in late middle age. The Pima Indians of Arizona have a very high prevalence of this disease and in contrast to many populations the disease often presents at an earlier age. As a result of the long-term epidemiologic studies, the familial nature of the disease has been well-documented, and segregation analysis suggests the possibility of a single major gene affecting age of onset. Genetic determinants of type 2 diabetes mellitus, its risk factors and its complications are being sought using techniques of genetic linkage analysis. Lymphoblast cell lines have been established from informative pedigrees have been established. DNA is available from other families in nuclear pellets extracted from blood specimens obtained during the epidemiologic studies. Polymorphic1 probes are applied to the DNA from selected individuals to search for evidence of linkage of these markers with diabetes and its complications. A genetic linkage mapping study has been completed for 1338 individuals in 112 pedigrees potentially informative for linkage studies of diabetes. Genotypes for 516 autosomal genetic markers have been determined. The results of these analyses identified strong evidence for a gene influencing both obesity and diabetes on chromosome 11 and evidence for additional diabetes-susceptibility genes on chromosomes 1 and 7. In addition, potential genes influencing susceptibility to diabetic nephropathy were identified on chromosomes 3, 7, 9 and 20. Efforts at extending these findings through genotyping individuals in additional pedigrees and through fine-mapping are now underway. Further work will focus on incorporating additional epidemiologic data into the genetic analyses.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Intramural Research (Z01)
Project #
1Z01DK069028-09
Application #
6162064
Study Section
Special Emphasis Panel (PECR)
Project Start
Project End
Budget Start
Budget End
Support Year
9
Fiscal Year
1997
Total Cost
Indirect Cost
City
State
Country
United States
Zip Code
Traurig, Michael; Mack, Janel; Hanson, Robert L et al. (2009) Common variation in SIM1 is reproducibly associated with BMI in Pima Indians. Diabetes 58:1682-9
Rong, Rong; Hanson, Robert L; Ortiz, Daniel et al. (2009) Association analysis of variation in/near FTO, CDKAL1, SLC30A8, HHEX, EXT2, IGF2BP2, LOC387761, and CDKN2B with type 2 diabetes and related quantitative traits in Pima Indians. Diabetes 58:478-88
Moore, Allan F; Jablonski, Kathleen A; McAteer, Jarred B et al. (2008) Extension of type 2 diabetes genome-wide association scan results in the diabetes prevention program. Diabetes 57:2503-10
Ma, Lijun; Hanson, Robert L; Que, Lorem N et al. (2008) PCLO variants are nominally associated with early-onset type 2 diabetes and insulin resistance in Pima Indians. Diabetes 57:3156-60
Ma, Lijun; Hanson, Robert L; Que, Lorem N et al. (2008) Association analysis of Kruppel-like factor 11 variants with type 2 diabetes in Pima Indians. J Clin Endocrinol Metab 93:3644-9
Saunders, Catherine L; Chiodini, Benedetta D; Sham, Pak et al. (2007) Meta-analysis of genome-wide linkage studies in BMI and obesity. Obesity (Silver Spring) 15:2263-75
Traurig, M; Hanson, R L; Kobes, S et al. (2007) Protein tyrosine phosphatase 1B is not a major susceptibility gene for type 2 diabetes mellitus or obesity among Pima Indians. Diabetologia 50:985-9
Hanson, Robert L; Bogardus, Clifton; Duggan, David et al. (2007) A search for variants associated with young-onset type 2 diabetes in American Indians in a 100K genotyping array. Diabetes 56:3045-52
Guo, Tingwei; Hanson, Robert L; Traurig, Michael et al. (2007) TCF7L2 is not a major susceptibility gene for type 2 diabetes in Pima Indians: analysis of 3,501 individuals. Diabetes 56:3082-8
Franks, P W; Jablonski, K A; Delahanty, L et al. (2007) The Pro12Ala variant at the peroxisome proliferator-activated receptor gamma gene and change in obesity-related traits in the Diabetes Prevention Program. Diabetologia 50:2451-60

Showing the most recent 10 out of 45 publications